| Product NDC: | 13668-008 | 
| Proprietary Name: | ZOLPIDEM TARTRATE | 
| Non Proprietary Name: | zolpidem tartrate | 
| Active Ingredient(s): | 10 mg/1 & nbsp; zolpidem tartrate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 13668-008 | 
| Labeler Name: | Torrent Pharmaceuticals Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077903 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20070905 | 
| Package NDC: | 13668-008-05 | 
| Package Description: | 500 TABLET in 1 BOTTLE (13668-008-05) | 
| NDC Code | 13668-008-05 | 
| Proprietary Name | ZOLPIDEM TARTRATE | 
| Package Description | 500 TABLET in 1 BOTTLE (13668-008-05) | 
| Product NDC | 13668-008 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | zolpidem tartrate | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20070905 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Torrent Pharmaceuticals Limited | 
| Substance Name | ZOLPIDEM TARTRATE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |